| Pharmaceutical active ingredients: |
| Benzoxonium ChlorideLidocaine Hydrochloride |
| Available forms, composition and doses of Mebuca-Orange: |
| Lozenges; Oral; Benzoxonium Chloride 1 mg; Lidocaine Hydrochloride 1 mg |
| Mebuca-Orange medical category: |
| Human:Mouth / throat preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R02AA20 - Antiseptics, various |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |